Resident Memory T Cells and Their Effect on Cancer

被引:22
作者
Craig, Daniel J. [1 ]
Creeden, Justin F. [1 ]
Einloth, Katelyn R. [1 ]
Gillman, Cassidy E. [1 ]
Stanbery, Laura [2 ]
Hamouda, Danae [1 ]
Edelman, Gerald [1 ]
Dworkin, Lance [1 ]
Nemunaitis, John J. [2 ]
机构
[1] Univ Toledo, Med Ctr, Dept Chem Engn, Toledo, OH 43614 USA
[2] Gradalis Inc, Carrollton, TX 75006 USA
关键词
memory T cells; immunotherapy; cancer vaccine; TUMOR-INFILTRATING LYMPHOCYTES; DENDRITIC CELLS; SURVIVAL; CD103; IMMUNOTHERAPY; TRAFFICKING; VACCINATION; RESPONSES; PROGRAMS; TISSUES;
D O I
10.3390/vaccines8040562
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Resident memory T (T-RM) cells are a unique subset of CD8(+) T cells that are present within certain tissues and do not recirculate through the blood. Long term memory establishment and maintenance are dependent on tissue population of memory T cells. They are characterized by dual CD69/CD103 positivity, and play a role in both response to viral infection and local cancer immunosurveillance. Human T-RM cells demonstrate the increased expression of adhesion molecules to facilitate tissue retention, have reduced proliferation and produce both regulatory and immune responsive cytokines. T-RM cell phenotype is often characterized by a distinct expression profile driven by Runx3, Blimp1, and Hobit transcription factors. The accumulation of T-RM cells in tumors is associated with increased survival and response to immunotherapies, including anti-PD-1 and anti-CTLA-4. In this review, we explore potential mechanisms of T-RM cell transformation and maintenance, as well as potential applications for the use of T-RM cells in both the development of supportive therapies and establishing more accurate prognoses.
引用
收藏
页码:1 / 14
页数:14
相关论文
共 97 条
  • [11] TMB: a promising immune-response biomarker, and potential spearhead in advancing targeted therapy trials
    Choucair, Khalil
    Morand, Susan
    Stanbery, Laura
    Edelman, Gerald
    Dworkin, Lance
    Nemunaitis, John
    [J]. CANCER GENE THERAPY, 2020, 27 (12) : 841 - 853
  • [12] Comber Joseph D, 2014, Ther Adv Vaccines, V2, P77, DOI 10.1177/2051013614525375
  • [13] Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs
    Cruz-Guilloty, Fernando
    Pipkin, Matthew E.
    Djuretic, Ivana M.
    Levanon, Ditsa
    Lotem, Joseph
    Lichtenheld, Mathias G.
    Groner, Yoram
    Rao, Anjana
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2009, 206 (01) : 51 - 59
  • [14] Adenovirus vector-based prime-boost vaccination via heterologous routes induces cervicovaginal CD8+ T cell responses against HPV16 oncoproteins
    Cuburu, Nicolas
    Khan, Selina
    Thompson, Cynthia D.
    Kim, Rina
    Vellinga, Jort
    Zahn, Roland
    Lowy, Douglas R.
    Scheper, Gert
    Schiller, John T.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2018, 142 (07) : 1467 - 1479
  • [15] Topical Herpes Simplex Virus 2 (HSV-2) Vaccination with Human Papillomavirus Vectors Expressing gB/gD Ectodomains Induces Genital-Tissue-Resident Memory CD8+ T Cells and Reduces Genital Disease and Viral Shedding after HSV-2 Challenge
    Cuburu, Nicolas
    Wang, Kening
    Goodman, Kyle N.
    Pang, Yuk Ying
    Thompson, Cynthia D.
    Lowy, Douglas R.
    Cohen, Jeffrey I.
    Schiller, John T.
    [J]. JOURNAL OF VIROLOGY, 2015, 89 (01) : 83 - 96
  • [16] Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches
    de la Cruz-Lopez, Karen G.
    Josue Castro-Munoz, Leonardo
    Reyes-Hernandez, Diego O.
    Garcia-Carranca, Alejandro
    Manzo-Merino, Joaquin
    [J]. FRONTIERS IN ONCOLOGY, 2019, 9
  • [17] Efficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer Phase 1b Results From the JAVELIN Solid Tumor Trial
    Disis, Mary L.
    Taylor, Matthew H.
    Kelly, Karen
    Beck, J. Thaddeus
    Gordon, Michael
    Moore, Kathleen M.
    Patel, Manish R.
    Chaves, Jorge
    Park, Haeseong
    Mita, Alain C.
    Hamilton, Erika P.
    Annunziata, Christina M.
    Grote, Hans Juergen
    von Heydebreck, Anja
    Grewal, Jaspreet
    Chand, Vikram
    Gulley, James L.
    [J]. JAMA ONCOLOGY, 2019, 5 (03) : 393 - 401
  • [18] CD8+ CD103+ Tumor-Infiltrating Lymphocytes Are Tumor-Specific Tissue-Resident Memory T Cells and a Prognostic Factor for Survival in Lung Cancer Patients
    Djenidi, Faycal
    Adam, Julien
    Goubar, Aicha
    Durgeau, Aurelie
    Meurice, Guillaume
    de Montpreville, Vincent
    Validire, Pierre
    Besse, Benjamin
    Mami-Chouaib, Fathia
    [J]. JOURNAL OF IMMUNOLOGY, 2015, 194 (07) : 3475 - 3486
  • [19] Tumor Resident Memory T Cells: New Players in Immune Surveillance and Therapy
    Dumauthioz, Nina
    Labiano, Sara
    Romero, Pedro
    [J]. FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [20] CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naive Melanoma Patients and Expand Significantly During Anti-PD-1 Treatment
    Edwards, Jarem
    Wilmott, James S.
    Madore, Jason
    Gide, Tuba Nur
    Quek, Camelia
    Tasker, Annie
    Ferguson, Angela
    Chen, Jinbiao
    Hewavisenti, Rehana
    Hersey, Peter
    Gebhardt, Thomas
    Weninger, Wolfgang
    Britton, Warwick J.
    Saw, Robyn P. M.
    Thompson, John F.
    Menzies, Alexander M.
    Long, Georgina V.
    Scolyer, Richard A.
    Palendira, Umaimainthan
    [J]. CLINICAL CANCER RESEARCH, 2018, 24 (13) : 3036 - 3045